Investments in startup- and growth stage companies. Exclusive focus on Austrian companies operating in the fields of biotechnology, medical technology and high technology.
Criteria for financing
Austrian companies operating in the fields of biotechnology, medical technology and high technology in the startup or growth stage.
Volume of financing
minimum of EUR 500,000.-
Scope of services
Financing, strategic and operative consulting, M&A consulting, tap into the company network, PR
- Nabriva Therapeutics GmbH 2010-2015 Financing of a phase II study of a new antibiotic. Exit through IPO on NASDAQ
- Mechatronic Systemtechnik GmbH 2009-2014 Financing of expansion. Exit trough buy-back.
- Marinomed Biotechnologie AG 2011-dato Financing of the development of a proprietory technology platform
- Biocrates Life Sciences AG 2010-dato Financing of the development of diagnostics in the field of metabolomics
- crystalsol GmbH 2012-dato Financing of the development of a new thin-film solar cells based on a proprietory CZTS-technology
T 01 370747414